Another vaccine submits a bid for Health Canada approval
Clinical trial participants are monitored during Novavax COVID-19 vaccine testing in Melbourne, Australia, in May. On Thursday, Novavax said its vaccine appears 89% effective based on early findings from a British study. (Patrick Rocca/Nucleus Network/ABC via AP) According to The Times’s Catherine Porter, they plan to start piloting tests in the workplace this month and expand the program to 1,200 small businesses. Porter writes that the companies “plan to share their test results with government health authorities, greatly raising test counts in the country and providing an informal stu...